Skip to main content

Advertisement

SpringerLink
Log in

Prognosis of autoimmune hemolytic anemia in critically ill patients

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Patients with autoimmune hemolytic anemia (AIHA) may require intensive care unit (ICU) admission. In order to describe the characteristics of AIHA patients in ICU and identify prognosis factors, clinical and biological data from 44 patients admitted in one ICU between 2002 and 2015 were retrospectively analyzed. The main reasons for ICU admission were profound anemia without any organ failure in 19 patients (either for safer transfusion or continuous monitoring only). Twenty-five (57%) patients had a past history of hemopathy. Twenty patients presented with a direct anti-globulin test (DAT) positive for immunoglobulin G (DAT-IgG) only (46%), 8 with a DAT positive for both IgG and complement (DAT-IgG+C) (36%), and 16 with a DAT positive for complement only (DAT-IgG+C) (18%). Corticosteroids and rituximab were administered to respectively 44 (100%) and 12 (25%) patients. Red blood cell transfusion was required in 28 (64%) patients. Ten (23%) patients received vasopressors. Renal replacement therapy was necessary in 14 (31.8%) patients. Thirteen (30%) patients died in the ICU. There was no difference between survivors and non-survivors regarding associated comorbidities like hemopathy (18/31 [58%] vs. 7/13 [54%], p = 0.80). In decedents, age was higher (72 years [57.8–76.3] vs. 50 years [34.3–64], p < 0.01) and organ dysfunctions were more severe at day 1 (SOFA 8 [7–11] vs. 5.5 [3–7], p < 0.01). Patients with a DAT-IgG displayed poorer outcome in comparison with patients with DAT-IgG+C/C (hospital mortality 69% vs. 36%, p = 0.04). Mortality rate of AIHA patients requiring ICU admission is consequential and appears to be impacted by age, organ failures, and DAT-IgG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gehrs BC, Friedberg RC (2002) Autoimmune hemolytic anemia. Am J Hematol 69(4):258–271

    Article  PubMed  Google Scholar 

  2. Michel M (2011) Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol 4(6):607–618

    Article  PubMed  Google Scholar 

  3. Moreno C, Hodgson K, Ferrer G, Elena M, Filella X, Pereira A, Baumann T, Montserrat E (2010) Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood 116(23):4771–4776

    Article  CAS  PubMed  Google Scholar 

  4. Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M, Limal N, Noizat-Pirenne F, Godeau B, Michel M (2014) Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single-center experience with 60 patients. Am J Hematol 89(9):E150–E155

    Article  CAS  PubMed  Google Scholar 

  5. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9(8):591–597

    Article  CAS  Google Scholar 

  6. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22(7):707–710

    Article  CAS  Google Scholar 

  7. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA 270(24):2957–2963

    Article  Google Scholar 

  8. Lengliné E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, Schlemmer B, Dombret H, Azoulay E (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 53(7):1352–1359

    Article  PubMed  Google Scholar 

  9. Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E et al (2014) Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood 124(19):2930–2936

    Article  CAS  PubMed  Google Scholar 

  10. Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E et al (2012) Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. Blood 119(16):3691–3697

    Article  CAS  PubMed  Google Scholar 

  11. Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, Bader-Meunier B, Robert A, Nelken B, Gandemer V, Savel H, Stephan JL, Fouyssac F, Jeanpetit J, Thomas C, Rohrlich P, Baruchel A, Fischer A, Chene G, Perel Y, for the Centre de Reference National des Cytopenies Auto-immunes de l'Enfant (CEREVANCE) (2011) New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 96(5):655–663

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit, Saint-Louis Teaching Hospital, AP-HP, Paris, France

    Antoine Lafarge, C. Pichereau, S. Valade, A. Chermak, I. Theodose, E. Canet, V. Lemiale, B. Schlemmer, E. Azoulay & E. Mariotte

  2. Department of Clinical Immunology, Saint-Louis Teaching Hospital, AP-HP, Paris, France

    R. Bertinchamp & L. Galicier

Authors
  1. Antoine Lafarge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Bertinchamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Pichereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Valade
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Chermak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Theodose
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Canet
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Lemiale
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Schlemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L. Galicier
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E. Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E. Mariotte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoine Lafarge.

Ethics declarations

The study was performed in accordance with the ethical standards of the Helsinki Declaration and was approved by our local institutional review board.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lafarge, A., Bertinchamp, R., Pichereau, C. et al. Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol 98, 589–594 (2019). https://doi.org/10.1007/s00277-018-3553-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3553-9

Keywords

Search

Navigation